Physician profile
Imran Mohiuddin
NPI 1538571062
$92,500.69
in general payments reported to CMS, 2019-2025
29 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $191 · 2021: $264 · 2022: $295 · 2023: $13K · 2024: $30K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Travel and Lodging: $25K · Honoraria: $13K · Food and Beverage: $6,229 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,290.00 |
| Travel and Lodging | $24,731.04 |
| Honoraria | $12,500.00 |
| Food and Beverage | $6,229.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $80,356.27 | 2023-2025 | Gammatile, Gammatile |
| Elekta, INC. | $8,003.26 | 2025 | Elekta Medical Linear Accelerator, Elekta Unity |
| Telix Pharmaceuticals | $2,011.93 | 2025 | Illuccix |
| Brainlab, INC. | $359.01 | 2021-2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Siemens Medical Solutions USA, INC. | $259.26 | 2021-2023 | Varian Ethos Treatment Planning |
| Novocure INC. | $241.39 | 2024 | Optune |
| Astrazeneca Pharmaceuticals LP | $170.74 | 2022-2025 | Imfinzi |
| Abbvie INC. | $124.99 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.73 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $79.35 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Blue Earth Diagnostics | $77.70 | 2024-2025 | Posluma |
| Advanced Bionics, LLC | $73.76 | 2020 | |
| Daiichi Sankyo INC. | $64.95 | 2024 | Enhertu |
| Varian Medical Systems, INC. | $60.55 | 2020 | |
| Novartis Pharmaceuticals Corporation | $57.36 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $56.88 | 2020 | |
| Tersera Therapeutics LLC | $48.92 | 2023-2024 | Zoladex |
| Monteris Medical Corporation | $48.22 | 2025 | Neuroblate |
| Tolmar, INC. | $46.27 | 2024-2025 | Eligard, Rubraca |
| Sumitomo Pharma America, INC. | $46.12 | 2023-2024 | Orgovyx |
| Napo Pharmaceuticals INC | $32.27 | 2024 | Gelclair Concentrated Oral Gel |
| Stryker Corporation | $31.58 | 2025 | Optablate |
| Ge Healthcare | $28.49 | 2024 | |
| Janssen Biotech, INC. | $24.79 | 2022 | |
| Pfizer INC. | $24.07 | 2024 | |
| Lemaitre Vascular, INC. | $20.56 | 2024 | Artegraft Vascular Graft |
| Pharmaand Gmbh | $18.58 | 2025 | Rubraca |
| Dendreon Pharmaceuticals LLC | $17.41 | 2023 | Provenge |
| Bard Peripheral Vascular, INC. | $6.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Mohiuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.